Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Endocrinology and Metabolism|September 1, 1985
Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486L K Nieman, G P Chrousos, C Kellner, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 12, 2001
The influence of age on the response of major depression to electroconvulsive therapy: a C.O.R.E. ReportM K O'Connor, R Knapp, M Husain, et al.
Marine Drugs|September 12, 2019
Bioactive Aliphatic Sulfates from Marine InvertebratesLuis C Kellner Filho, Bruno W Picão, Marcio L A Silva, et al.
Anti-Cancer Drugs|September 7, 1999
Heterogeneity of chemosensitivity of metastatic cutaneous melanomaI A Cree, M H Neale, N E Myatt, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 25, 2025
KOH 5% solution versus diclofenac 3% for the treatment of actinic keratosis - Results from a three-armed RCTU Reinhold, N Leitz, R Dominicus, et al.
Scandinavian Journal of Immunology|July 15, 2017
CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma CellsM Peipp, D Wesch, H-H Oberg, et al.
The British Journal of Dermatology|May 21, 2014
Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial on efficacy and safetyJ Malvehy, A Hauschild, C Curiel-Lewandrowski, et al.
Leukemia|June 5, 2012
The novel tribody [(CD20)(2)xCD16] efficiently triggers effector cell-mediated lysis of malignant B cellsP Glorius, A Baerenwaldt, C Kellner, et al.
Journal of Immunological Methods|July 16, 2011
Human kappa light chain targeted Pseudomonas exotoxin A--identifying human antibodies and Fab fragments with favorable characteristics for antibody-drug conjugate developmentC Kellner, W K Bleeker, J J Lammerts van Bueren, et al.
The British Journal of Dermatology|February 13, 2018
A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapyC A Morton, R Dominicus, P Radny, et al.
Pageof 13